Status:
COMPLETED
The COVID-19 Disease and CARdiac Events Study
Lead Sponsor:
NHS Lanarkshire
Conditions:
COVID
Coronavirus
Eligibility:
All Genders
18+ years
Brief Summary
An observational study of consecutive patients testing positive for COVID-19 who require admission to hospital to determine the degree of myocardial injury through biomarkers and echocardiography and ...
Detailed Description
Purposes: 1. To determine the prevalence of myocardial injury/impairment in patients hospitalised with COVID-19 disease. 2. To determine the predictive value of baseline biomarkers in identifying pat...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- In-patient in UHH within first 5 days of admission
- COVID-19 disease confirmed on rtPCR detection of SARS-CoV-2 from nasopharyngeal swabs and/or thoracic X-ray imaging findings characteristic of COVID-19 disease (positive swab results preferred).
- Able to provide written, informed consent.
Exclusion
- Refusal of consent for enrolment.
- Known pre-existing left ventricular systolic dysfunction with left ventricular ejection fraction (LVEF) \<40%.
Key Trial Info
Start Date :
May 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 29 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04438993
Start Date
May 29 2020
End Date
January 29 2021
Last Update
April 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Hairmyres
Glasgow, Scotland, United Kingdom, G75 8RG